keyboard_arrow_up

Pen Needles Market worth $2,105 Million by 2019

The “Pen Needles Market by Type (Standard and Safety), by Needle Length (4mm, 5mm, 6mm, 8mm, 10mm, and 12mm), by Therapy (Insulin, Glucagon-like peptide, Growth Hormones) - Analysis & Global Forecast to 2019”, analyzes and studies the major market drivers, threats, opportunities, and challenges. This report studies the global pen needles marketfor the forecast period of 2014 to 2019.This market is expected to reach $2,105 million by 2019 from$1,283 millionin 2014, and is poised to grow at a CAGR of 10.4% during the forecast period.

Browse 104 market data tables and 62 figures spread through 169 pages and in-depth TOC on “Pen Needles Market”
http://www.marketsandmarkets.com/Market-Reports/pen-needles-market-75948613.html
Early buyers will receive 10% customization on this report.


The global pen needles market is segmented on the basis of type, needle length, therapy,and regions.

Based on type, the market is categorized into standard and safety pen needles.The standard pen needles segment is expected to account fora major share of the market, by type in 2014.

On the basis of needle length, the market is segmented into 4 mm, 5 mm, 6 mm, 8 mm, 10 mm, and 12mm. Pen needles with 6mm length are expected to account for a major share of the market, by needle length in 2014. On the basis of therapy, the market is segmented into insulin, Glucagon-like peptide (GLP), and growth hormones. Insulin therapy account for major share of the market, by therapy in 2014.

Talk to Our Research Analysts for More Info@
http://www.marketsandmarkets.com/speaktoanalyst.asp?id=75948613

On the basis of regions, the market is divided into North America, Europe, Asia, and Rest of the World (RoW). Rest of the World comprises Latin America, Pacific countries, and Middle East and Africa. Europe accounts for the largest share in the market, followed by North America and Asia. However, the Asian market is slated to grow at the highest CAGR inthe coming five years and serves as a revenue pocket for the companies involved in the manufacturing of needles.

Over the years, the demand for pen needles is likely to increase owing to favorable reimbursement environment in North America and Europe, strong government support in the Pacific region, advantages of insulin pens over syringes and vials, technological advancements in pen needle technologies, and growing diabetic population. However, poor reimbursement structure in developing countries, severe shortage of Endocrinologists in the U.S., threats involved in reuse of needles, rising incidents of needlestick injuries (NSIs), and alternative drug delivery methods are restraining the growth of this market. Rising use of safety needles is likely to create opportunities for the market. However, minimizing the usage of standard pen needles still remains a challenge for this market.

Get The Sample Copy Of This Report:
http://www.marketsandmarkets.com/requestsample.asp?id=75948613

Some of the major players in the global market include Becton, Dickinson and Company (U.S.), Novo Nordisk Denmark), Ypsomed Holding AG (Switzerland), B. Braun Melsungen AG (Germany), HTL-Strefa S.A. (Poland), Terumo Corporation (Japan), Artsana S.p.a (Italy), Owen Mumford Ltd (U.K.), Allison Medical, Inc. (U.S.), and Ultimed, Inc. (U.S.).

About MarketsandMarkets:
MarketsandMarkets is world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.

M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Subscribe Reports from Healthcare Domain @ http://www.marketsandmarkets.com/Subscription.html

Contact:
Mr. Rohan

Unit No. 802, 8th Floor,
Tower - 7, Magarpatta City SEZ,
Hadapsar, Pune – 411013,
Maharashtra, India.
Tel: +1-888-6006-441.
Email: sales@marketsandmarkets.com
Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/medical-devices
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets